Using Ultra-Low Freezers to Maintain the Viability of Cell and Gene Therapy Products

Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage, which affect numerous steps of the biomedical solutions’ life cycles, from their development to their administration.

The key prerequisite for any preservation method is the product stability it can offer for successful clinical outcomes. Expensive and cumbersome preservation methods also contribute significantly to the cost of these technologies and limit the use of cell and gene therapy products. As a result, reliable but simple-to-use and cheaper approaches are critical for the adoption and sustainability of such scientific applications.